OSSTEM CARDIO Co., Ltd.
OSSTEM CARDIO Co., Ltd. , specialized in cardiovascular medical devices, has started to develop cardiovascular stent for the first time in Korea in 2011. We have researched and developed to localize Drug Eluting Coronary Stent which heavily depends on the import for a long time. As a result of a long R&D, Everolimus Eluting Stent(the 3rd-generation drug eluting stent) is released in 2021. Based on our own technology, we are constantly challenging the development to cardiovascular medical devices with superior quality and safety, such as drug eluting coronary stent(DES), PTCA balloon catheter and balloon inflator.